Reaction

Vein Disorder reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 4,981 reports · 124 co-occurring drugs

As of the last recalculation, Vein Disorder appears in 4,981 FAERS reports alongside 124 co-occurring drug terms. The strongest observed disproportionality signal is NATALIZUMAB (PRR 16.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Natalizumab	618	16.1	16.1
Diphenhydramine Hydrochloride Capsule, Liquid Filled	67	13.3	13.3
Human Immunoglobulin G	51	10.4	10.4
Canakinumab	24	9.3	9.3
Belimumab	55	7.3	7.3
Fulvestrant	56	7.2	7.2
Valsartan And Hydrochlorothiazide	23	7.1	7.1
Agalsidase Beta	15	6.8	6.8
Iron Sucrose	15	6.6	6.6
Cyclobenzaprine Hydrochloride	14	6.5	6.5
Risedronate Sodium	47	6.4	6.4
Adrenalinum	56	5.7	5.7
Eculizumab	71	5.5	5.5
Infliximab-Dyyb	38	5.5	5.5
Ribociclib	41	5.5	5.5
Methylprednisolone Sodium Succinate	59	5.4	5.4
Alemtuzumab	24	5.2	5.2
Teriparatide	136	5.2	5.2
Dicyclomine Hydrochloride	17	5.0	5.0
Bendamustine Hydrochloride	14	4.9	4.9
Interferon Beta-1A	217	4.9	4.9
Sucralfate Oral	16	4.7	4.7
Sucralfate Oral Suspension	16	4.7	4.7
Diphenhydramine Hydrochloride	180	4.7	4.7
Cetirizine Hcl	10	4.6	4.6
Anastrozole Tablets	23	4.5	4.5
Hydrocortisone Sodium Succinate	10	4.5	4.5
Olmesartan Medoxomil	38	4.4	4.4
Dalteparin Sodium	11	4.4	4.4
Diphenhydramine	65	4.3	4.3
Amlodipine Besylate And Valsartan	11	4.2	4.2
Diphenhydramine Hcl	11	4.1	4.1
Nitrofurantoin (Monohydrate/Macrocrystals)	16	4.0	4.0
Epinephrine	62	4.0	4.0
Nitrofurantoin	15	3.8	3.8
Drospirenone And Ethinyl Estradiol	40	3.8	3.8
Avapritinib	11	3.8	3.8
Tocilizumab	101	3.8	3.8
Raloxifene Hydrochloride	13	3.7	3.7
Sucralfate	21	3.7	3.7
Octreotide Acetate	26	3.6	3.6
Sodium Chloride	66	3.5	3.5
Zoledronic Acid	33	3.5	3.5
Anastrozole	30	3.4	3.4
Mometasone	15	3.4	3.4
Clarithromycin	28	3.4	3.4
Sodium Chloride Tablet	59	3.4	3.4
Sodium Chloride Tablets	59	3.4	3.4
Lidocaine	46	3.3	3.3
Letrozole	48	3.3	3.3
Iron	52	3.3	3.3
Paricalcitol	11	3.3	3.3
Hydroxyzine Hydrochloride	10	3.2	3.2
Hydroxyzine Hydrochloride Oral	10	3.2	3.2
Aprepitant	14	3.2	3.2
Folic Acid	179	3.1	3.1
Ezetimibe And Simvastatin	11	3.0	3.0
Carfilzomib	20	3.0	3.0
Pertuzumab	19	2.9	2.9
Letrozole Tablets	33	2.9	2.9
Abatacept	94	2.9	2.9
Oxybutynin Chloride	6	2.9	2.9
Modafinil	22	2.9	2.9
Clobetasol Propionate Ointment Usp, 0.05%	7	2.8	2.8
Rucaparib	6	2.8	2.8
Clobetasol Propionate	7	2.8	2.8
Ravulizumab	9	2.8	2.8
Hydroxychloroquine	49	2.8	2.8
Everolimus	33	2.7	2.7
Emicizumab	8	2.7	2.7
Trastuzumab	43	2.6	2.6
Amphetamine	5	2.5	2.5
Infliximab	128	2.5	2.5
Dronedarone	6	2.5	2.5
Atorvastatin Calcium, Film Coated	41	2.5	2.5
Fosaprepitant Dimeglumine	8	2.4	2.4
Acetaminophen And Codeine	7	2.4	2.4
Apixaban	38	2.4	2.4
Insulin Human	22	2.3	2.3
Fesoterodine Fumarate	6	2.3	2.3
Nilotinib	16	2.3	2.3
Ocrelizumab	33	2.2	2.2
Glatiramer Acetate	31	2.2	2.2
Polatuzumab Vedotin	5	2.1	2.1
Palbociclib	47	2.1	2.1
Prasugrel Hydrochloride	5	2.1	2.1
Budesonide, Glycopyrrolate, And Formoterol Fumarate	5	2.0	2.0
Romiplostim	7	1.9	1.9
Deferasirox	12	1.9	1.9
Capecitabine	41	1.9	1.9
Bosentan	22	1.8	1.8
Diroximel Fumarate	5	1.8	1.8
Interferon Beta-1B	8	1.7	1.7
Docetaxel Anhydrous	27	1.7	1.7
Docetaxel	27	1.7	1.7
Sacubitril And Valsartan	46	1.7	1.7
Nintedanib	12	1.6	1.6
Sarilumab	10	1.6	1.6
Isotretinoin	18	1.5	1.5
Tofacitinib	65	1.5	1.5
Dimethyl Fumarate	43	1.5	1.5
Alpelisib	3	1.4	1.4
Risankizumab-Rzaa	28	1.4	1.4
Siponimod	3	1.4	1.4
Teriflunomide	15	1.4	1.4
Venetoclax	20	1.4	1.4
Botulinum Toxin Type A	4	1.3	1.3
Dalfampridine	23	1.3	1.3
Cetuximab	10	1.3	1.3
Dabigatran Etexilate Mesylate	23	1.3	1.3
Rimegepant Sulfate	4	1.3	1.3
Voxelotor	7	1.3	1.3
Abemaciclib	6	1.3	1.3
Fam-Trastuzumab Deruxtecan-Nxki	3	1.2	1.2
Romosozumab-Aqqg	4	1.2	1.2
Ambrisentan	35	1.2	1.2
Alirocumab	6	1.0	1.0
Onabotulinumtoxina	18	1.0	1.0
Pegfilgrastim	19	0.8	0.8
Galcanezumab-Gnlm	6	0.8	0.8
Evolocumab	30	0.8	0.8
Pomalidomide	18	0.7	0.7
Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride	5	0.7	0.7
Adapalene	3	0.1	0.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.